AccuStem Sciences, Inc. (ACUT) - Latest Market Data

Price & Market Data

Price: $0.55

Daily Change: $0.00 / 0.00%

Range: $0.42 - $0.55

Market Cap: $6,655,275

Volume: 4,219

Performance Metrics

1 Week: -14.44%

1 Month: -6.67%

3 Months: 4.28%

6 Months: 4.41%

1 Year: 52.17%

YTD: -1.18%

Company Details

Employees: 2

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing products for the treatment and management of various cancers. Its primary product candidate is StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company was founded in 2013 and is headquartered in New York, New York.

Selected stocks

Zealand Pharma A/S (ZLDPF)

Else Nutrition Holdings Inc. (BABYF)

Rubicon Organics Inc. (ROMJF)